Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,544 people get BAX articles and Market Currents by email alert.
Get email alerts on BAX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Tue, 9:00AM)
-
Business Wire (Mon, 9:00AM)
-
-
-
-
-
-
-
Baxter International Inc. - Special CallTue, May 7
-
Business Wire (May 7, 2013)
-
Business Wire (May 6, 2013)
-
-
Business Wire (Apr 25, 2013)
-
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 24, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
Why We Like Baxter's DividendValuentum • Thu, Oct 25, 2012 -
-
-
-
Baxter Still Defensive, But Is Now The Time For Offense?Stephen Simpson • Tue, May 15, 2012 -
Baxter Earnings PreviewZacks Investment Research • Tue, Apr 17, 2012 -
-
Baxter's A Buy For Growth, Cash Flow, And Rising DividendsIngrid Hendershot • Tue, Mar 13, 2012 -
-
-
-
-
Baxter International Inc. - Special CallTue, May 7
-
Baxter International Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
Baxter International Inc. Q1 2010 Earnings Call TranscriptThu, Apr 22, 2010
-
Baxter International Inc. Q4 2009 Earnings Call TranscriptThu, Jan 28, 2010
-
Baxter International Inc. Q3 2009 Earnings Call TranscriptThu, Oct 15, 2009
-
Baxter International Inc. Q2 2009 Earnings Call TranscriptThu, Jul 16, 2009
-
Business Wire (Tue, 9:00AM)
-
Business Wire (Mon, 9:00AM)
-
at CNBC.com (Fri, 6:02PM)
-
at CNBC.com (May 7, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 18, 2013)
-
at CNBC.com (Apr 17, 2013)
-
at MarketWatch.com (Apr 8, 2013)
-
Business Wire (Mar 27, 2013)
-
Business Wire (Feb 27, 2013)
-
Business Wire (Feb 19, 2013)
BAX vs. ETF Alternatives
Company Description
Baxter develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 18, 9:03 AM More on Baxter (BAX) Q1: net profit -11% to $552M, dragged down by charges related to its purchase of Gambrro, while last year's figures included a tax benefit. Medical-products sales -0.4% to $1.92B, BioScience revenue +4.7% to $1.53B. Expects sales growth of 4% in Q2 and 10% for FY; forecasts EPS of Q2 EPS of $1.12-1.14 vs consensus of $1.14 and 2014 EPS of $4.60-4.70 vs 4.66. (PR) Comment! [Healthcare, Earnings]
- Thursday, April 18, 7:03 AM Baxter (BAX): Q1 EPS of $1.05 in-line. Revenue of $3.45B (+2% Y/Y) misses by $0.04B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, April 18, 12:05 AM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
- Wednesday, April 17, 5:30 PM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
- Thursday, January 24, 9:14 AM More on Baxter's (BAX) Q4 results: Forecasts current-quarter EPS of $1.03-$1.05 on 2%-3% sales growth vs. consensus of $1.10 on 4% revenue growth to $3.5B. Forecasts 2013 EPS of $4.60-$4.70 on 10% sales growth vs. consensus $4.84 on 5% revenue growth of $14.8B. Acquires investigational hemophilia compound OBI-1 and related assets from Inspiration BioPharmaceuticals. Comment! [Earnings, Healthcare]
- Thursday, January 24, 7:03 AM Baxter (BAX): Q4 EPS of $1.26 in-line. Revenue of $3.8B (+4% Y/Y) beats by $0.08B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, January 24, 12:05 AM Notable earnings before Thursday’s open: ABC, ALK, ARG, AVT, BAX, BMY, BPOP, CELG, CY, DOV, EQT, ESI, ETN, FCS, GWW, JNS, JVA, KCG, KEY, LMT, LUV, MKC, MMM, MWW, NMM, NOK, ORI, PCP, QSII, RTN, RYN, SWK, TZOO, UAL, UNP, XRX Comment! [Earnings]
- Wednesday, January 23, 5:30 PM Notable earnings before Thursday’s open: ABC, ALK, ARG, AVT, BAX, BMY, BPOP, CELG, CY, DOV, EQT, ESI, ETN, FCS, GWW, JNS, JVA, KCG, KEY, LMT, LUV, MKC, MMM, MWW, NMM, NOK, ORI, PCP, QSII, RTN, RYN, SWK, TZOO, UAL, UNP, XRX Comment! [Earnings]
- Tuesday, December 4, 2012, 9:07 AM More on Baxter (BAX) / Gambro deal: the acquisition, Baxter's largest ever, combines the second and third largest manufacturers of dialysis equipment, so it could arouse antitrust concerns. Baxter expects synergies of $300M a year by 2017, but says the deal will cut adjusted EPS by $0.10-$0.15 next year and be neutral or add to earnings in 2014, and then add to profit after that. (Webcast) (PR) Comment! [M&A, Healthcare, Top Stories, Earnings]
- Thursday, October 18, 2012, 7:04 AM Baxter (BAX): Q3 EPS of $1.14 in-line. Revenue of $3.48B (flat% Y/Y) misses by $40M. (PR) Comment! [Earnings, Healthcare]
- Thursday, October 18, 2012, 12:05 AM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ Comment! [Earnings]
- Wednesday, October 17, 2012, 5:30 PM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ 2 Comments [Earnings]
- Thursday, July 19, 2012, 10:42 AM More on Baxter (BAX +1%) Q2: net profit rises to $661M from $615M despite forex hurting revenue growth. Announces deal with Holland's Sanquin Blood Supply Foundation to support the growth of Baxter's plasma-derived treatments. Guidance: Q3 EPS $1.12-$1.14 vs consensus of $1.16, sales growth of 1% vs. 2%; FY $4.50-$4.56 vs. $4.49-$4.57 prior forecast and $4.52 consensus. Comment! [Earnings, Healthcare]
- Thursday, July 19, 2012, 7:13 AM Baxter International (BAX): Q2 EPS of $1.12 beats by $0.01. Revenue of $3.57B (+1.0% Y/Y) beats by $40M. (PR) Comment! [Earnings, Healthcare]
- Thursday, July 19, 2012, 12:05 AM Notable earnings before Thursday’s open: ADS, BAX, BBT, BX, CY, DGX, DHR, DO, FCS, FCX, FITB, GPC, HBAN, JCI, KEY, LUV, MS, NOK, NUE, NVS, PM, SHW, SWY, TCB, TRV, TSM, TXT, UNH, UNP, VZ Comment! [Earnings]
- Wednesday, July 18, 2012, 5:30 PM Notable earnings before Thursday’s open: ADS, BAX, BBT, BX, CY, DGX, DHR, DO, FCS, FCX, FITB, GPC, HBAN, JCI, KEY, LUV, MS, NOK, NUE, NVS, PM, SHW, SWY, TCB, TRV, TSM, TXT, UNH, UNP, VZ Comment! [Earnings]
-
WhisperNumber
Alerts issued this morning for $AXP, $BAX, $FITB, $UNP, and $VZ. http://bit.ly/17e4eoA - View all 0 replies
-
WhisperNumber
$BAX earnings $1.05, seven cents short of the whisper number. Expected price reaction: http://seekingalpha.com/a/swgf - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Julius Ferraro
Out of BAX and into HAL. I've never had a better 3 days of trading. Doubled my gains for the year in 3 days :) - View all 0 replies
-
- View all 0 replies
LATEST REPLIES